2.50
前日終値:
$2.57
開ける:
$2.57
24時間の取引高:
23,478
Relative Volume:
0.01
時価総額:
$6.64M
収益:
$556.00K
当期純損益:
$-5.28M
株価収益率:
-1.1682
EPS:
-2.14
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
-11.35%
1か月 パフォーマンス:
-6.37%
6か月 パフォーマンス:
-3.47%
1年 パフォーマンス:
-21.88%
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
名前
Cyclerion Therapeutics Inc
セクター
電話
617-621-7722
住所
301 BINNEY STREET, CAMBRIDGE, MA
CYCN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
CYCN
Cyclerion Therapeutics Inc
|
2.50 | 6.64M | 556.00K | -5.28M | -6.23M | -2.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-10-20 | 開始されました | Truist | Buy |
2021-09-24 | 開始されました | Cantor Fitzgerald | Overweight |
2019-06-03 | 開始されました | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc (CYCN) 最新ニュース
Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart
Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL
3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St
Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register
Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex
Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat
Cyclerion Therapeutics announces mixed shelf offering - MSN
Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News
3 Penny Stocks to Watch Now, 2/4/25 - TipRanks
A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily
Analyzing CYCN’s current quarter earnings projections - US Post News
Biotech Alert: Searches spiking for these stocks today - TipRanks
Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn
Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn
Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
Cyclerion Therapeutics (NASDAQ:CYCN) Shares Up 3.5% – Time to Buy? - Defense World
Looking Into Cyclerion Therapeutics's Recent Short Interest - Benzinga
Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress - Stocks Telegraph
Cyclerion Therapeutics (NASDAQ: CYCN) Amends License Agreement with Akebia Therapeutics and Generates Revenues for GrowthOn December 17, 2024, Cyclerion Therapeutics, Inc. filed an 8-K SEC Filing which detailed significant developments in its b - Defense World
Cyclerion advances growth strategy with new agreements - Investing.com
Cyclerion Therapeutics Secures Funding and Expands CNS Focus - TipRanks
Cyclerion advances growth strategy with new agreements By Investing.com - Investing.com UK
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewswire
Cyclerion Therapeutics Inc (CYCN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):